Inflammaging: Disturbed interplay between autophagy and inflammasomes

Aging

Volumn 4, Issue 3, 2012, Pages 166-175

  Salminen, Antero ^a,b   Kaarniranta, Kai ^a,b   Kauppinen, Anu ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Aging; Autophagy; Inflammasome; Inflammation; Mitochondria; NF B

Indexed keywords

EID: 84863329778     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100444     Document Type: Article

References (128)

1. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. NY. Acad. Sci. 2000; 908: 244-254.
2. Larbi A, Franceschi C, Mazzatti D, Solana R, Wikby A, Pawelec G. Aging of the immune system as a prognostic factor for human longevity. Physiology 2008; 23:64-74.
3. Kovacs EJ, Palmer JL, Fortin CF, Fulop Jr T, Goldstein DR, Linton PJ. Aging and innate immunity in the mouse: impact of intrinsic and extrinsic factors. Trends Immunol. 2009; 30: 319-324.
4. Csiszar A, Ungvari Z, Koller A, Edwards JG, Kaley G. Aginginduced proinflammatory shift in cytokine expression profile in rat coronary arteries. FASEB J 2003; 17: 1183-1185.
5. de Magalhaes JP, Curado J, Church GM. Meta-analysis of agerelated gene expression profiles identifies common signatures of aging. Bioinformatics 2009; 25: 875-881.
6. Swindell WR. Genes and gene expression modules associated with caloric restriction and aging in the laboratory mouse. BMC Genomics 2009; 10: 585.
7. Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp. Gerontol. 2004; 39: 687-699.
8. Singh T, Newman AB. Inflammatory markers in population studies of aging. Ageing Res. Rev. 2010; 10: 319-329.
9. Helenius M, Hänninen M, Lehtinen SK, Salminen A. Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-κB. Biochem. J. 1996; 318: 603-608.
10. Adler AS, Sinha S, Kawahara TL, Zhang JY, Segal E, Chang HY. Motif module map reveals enforcement of aging by continual NF-κB activity. Genes Dev. 2007; 21: 3244-3257.
11. Salminen A, Huuskonen J, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T. Activation of innate immunity system during aging: NF-κB signaling is the culprit of inflamm-aging. Ageing Res. Rev. 2008; 7: 83-105.
12. Cevenini E, Caruso C, Candore G, Capri M, Nuzzo D, Duro G, Rizzo C, Colonna-Romano G, Lio D, Di Carlo D, Palmas MG, Scurti M, Pini E, Franceschi C, Vasto S. Age-related inflammation: the contribution of different organs, tissues and systems. How to face it for therapeutic approaches. Curr. Pharm. Des. 2010; 16; 609-618.
13. Giunta G. Exploring the complex relations between inflammation and aging (inflamm-aging): anti-inflamm-aging remodelling of inflamm-aging, from robustness to frailty. Inflamm. Res. 2008; 57: 558-563.
14. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani GC, Salvioli S. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Age. Dev. 2007; 128: 92-105.
15. Chen G, Shaw MH, Kim YG, Nunez G. NOD-like receptors: role in innate immunity and inflammatory disease. Annu. Rev. Pathol. Mech. Dis. 2009; 4: 365-398.
16. Schroder K, Tschopp J. The inflammasomes. Cell 2010; 140: 821-832.
17. Gross O, Thomas CJ, Guarda G, Tschopp J. The inflammasome: an integrated view. Immunol. Rev. 2011; 243: 136-151.
18. Kersse K, Bertrand MJM, Lamkanfi M, Vandenabeele P. NOD-like receptors and the innate immune system: coping with danger, damage and death. Cytokine Growth Factor Rev. 2011; 22: 257-276.
19. Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ. 2007; 14: 10-22.
20. Yazdi AS, Guarda G, D'Ombrain MC, Drexler SK. Inflammatory caspases in innate immunity and inflammation. J. Innate Immun. 2010; 2: 228-237.
21. Bauernfeind F, Ablasser A, Bartok E, Kim S, Schmid-Burgk J, Cavlar T, Hornung V. Inflammasomes: current understanding and open questions. Cell. Mol. Life Sci. 2011; 68: 765-783.
22. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks BG, Fitzgerald KA, Hornung V, Latz E. Cutting edge: NF-κB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 2009; 183: 787-791.
23. Piva R, Belardo G, Santoro MG. NF-κB: a stress-regulated switch for cell survival. Antioxid. Redox Signal. 2006; 8: 478-486.
24. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454: 428-435.
25. Petrilli V, Papin S, Dostert C, Mayor A, Martinon F, Tschopp J. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 2007; 14: 1583-1589.
26. Cruz CM, Rinna A, Forman HJ, Ventura ALM, Persechini PM, Ojcius DM. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J. Biol. Chem. 2007; 282: 2871-2879.
27. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 2010; 11: 136-140.
28. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ, Golenbock DT. The NALP3 inflammasome is involved in the innate immune response to amyloid-ß. Nature Immunol. 2008; 9: 857-865.
29. Niemi K, Teirilä L, Lappalainen J, Rajamäki K, Baumann MH, Öörni K, Wolff H, Kovanen PT, Matikainen S, Eklund KK. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and cathepsin B-sensitive pathway. J. Immunol. 2011; 186: 6119-6128.
30. Rajamäki K, Lappalainen J, Öörni K, Välimäki E, Matikainen S, Kovanen PT, Eklund KK. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS One 2010; 5: e11765.
31. Masters SL, O'Neill LA. Disease-associated amyloid and misfolded protein aggregates activate the inflammasome. Trends Mol. Med. 2011; 17: 276-282.
32. Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MTH, Brickey WJ, Ting JPY. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 2011; 12: 408-415.
33. Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, Ravussin E, Stephens JM, Dixit VD. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 2011; 17: 179-188.
34. Stienstra R, van Diepen JA, Tack CJ, Zaki MH, van de Veerdonk FL, Perera D, Neale GA, Hooiveld GJ, Hijmans A, Vroegrijk I, van den Berg S, Romijn J, Rensen PC, Joosten LA, Netea MG, Kanneganti TD. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc. Natl. Acad. Sci. USA 2011; 108: 15324-15329.
35. Schroder K, Zhou R, Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger? Science 2010; 327: 296-300.
36. Tschopp J, Schroder K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat. Rev. Immunol. 2010; 10: 210-215.
37. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011; 469: 221-225.
38. Deretic V. Autophagy in infection. Curr. Opin. Cell Biol. 2010; 22: 252-262.
39. Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M, Green-Thompson ZW, Jimenez-Sanchez M, Korolchuk VI, Lichtenberg M, Luo S, Massey CO, Menzies FM, Moreau K, Narayanan U, Renna M, Siddiqi FH, Underwood BR, Winslow AR, Rubinsztein DC. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol. Rev. 2010; 90: 1383-1436.
40. He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 2009; 43: 67-93.
41. Deretic V. Multiple regulatory and effector roles of autophagy in immunity. Curr. Opin. Immunol. 2009; 21: 53-62.
42. Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature 2011; 469: 323-335.
43. Singh R, Cuervo AM. Autophagy in the cellular energetic balance. Cell Metab. 2011; 13: 495-504.
44. Dong H, Czaja MJ. Regulation of lipid droplets by autophagy. Trends Endocrinol. Metab. 2011; 22: 234-240.
45. Choi AJS, Ryter SW. Autophagy in inflammatory diseases. Int. J. Cell Biol. 2011; Article ID 732798.
46. Fesus L, Demeny MA, Petrovski G. Autophagy shapes inflammation. Antioxid. Redox Signal. 2011; 14: 2233-2243.
47. Jo EK, Shin DM, Choi AMK. Autophagy: cellular defence to excessive inflammation. Microbes Infect. 2012; 14: 119-125.
48. Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, Satoh T, Omori H, Noda T, Yamamoto N, Komatsu M, Tanaka K, Kawai T, Tsujimura T, Takeuchi O, Yoshimori T, Akira S. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production. Nature 2008; 456: 264-268.
49. Yoshizaki T, Kusunoki C, Kondo M, Yasuda M, Kume S, Morino K, Sekine O, Ugi S, Uzu T, Nishio Y, Kashiwagi A, Maegawa H. Autophagy regulates inflammation in adipocytes. Biochem. Biophys. Res. Commun. 2012; 417: 352-357.
50. Lee HM, Shin DM, Yuk JM, Shi G, Choi DK, Lee SH, Huang SM, Kim JM, Kim CD, Lee JH, Jo EK. Autophagy negatively regulates keratinocytes inflammatory responses via scaffolding protein p62/SQSTM1. J. Immunol. 2011; 186: 1248-1258.
51. Meng Q, Cai D. Defective hypothalamic autophagy directs the central pathogenesis of obesity via the IκB kinase β (IKKβ)/NF-κB pathway. J. Biol. Chem. 2011; 286; 32324-32332.
52. Hsieh CH, Pai PY, Hsueh HW, Yuan SS, Hsieh YC. Complete induction of autophagy is essential for cardioprotection in sepsis. Ann. Surg. 2011; 253: 1190-1200.
53. Shi CS, Shenderov K, Huang NN, Kabat J, Abu-Asab M, Fitzgerald KA, Sher A, Kehrl JH. Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction. Nat. Immunol. 2012; 13: 255-263.
54. Arnoult D, Soares F, Tattoli I, Girardin SE. Mitochondria in innate immunity. EMBO Rep. 2011; 12: 901-910.
55. West AP, Shadel GS, Ghosh S. Mitochondria in innate immune responses. Nat. Rev. Immunol. 2011; 11: 389-402.
56. Krysko DV, Agostimis P, Krysko O, Garg AD, Bachert C, Lambrecht BN, Vandenabeele P. Emerging role of damageassociated molecular patterns derived from mitochondria in inflammation. Trends Immunol. 2011; 32: 157-164.
57. Nakahira K, Haspel JA, Rathinam VAK, Lee SJ, Dolinay T, Lam HC, Englert JA, Rabinovitch M, Cernadas M, Kim HP, Fitzgerald KA, Ryter SW, Choi AMK. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 2011; 8: 222-230.
58. Xiang M, Shi X, Li Y, Xu J, Yin L, Xiao G, Scott MJ, Billiar TR, Wilson MA, Fan J. Hemorrhagic shock activation of NLRP3 inflammasome in lung endothelial cells. J. Immunol. 2011; 187: 4809-4817.
59. Scherz-Shouval R, Elazar Z. Regulation of autophagy by ROS: physiology and pathology. Trends Biochem. Sci. 2011; 36: 30-38.
60. de Rivero Vaccari JP, Lotocki G, Alonso OF, Bramlett HM, Dietrich WD, Keane RW. Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after brain injury. J. Cereb. Blood Flow Metab. 2009; 29: 1251-1261.
61. Martinez-Vicente M, Cuervo AM. Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurol. 2007; 6: 352-361.
62. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132: 27-42.
63. Nixon RA, Yang DS. Autophagy failure in Alzheimer's disease - locating the primary defect. Neurobiol. Dis. 2011; 43: 38-45.
64. Davis BK, Wen H, Ting JP. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 2011; 29: 707-735.
65. Lamkanfi M, Vande Walle L, Kanneganti TD. Deregulated inflammasome signaling in disease. Immunol. Rev. 2011; 243: 163-173.
66. Brunk UT, Terman A. The mitochondrial-lysosomal axis theory of aging. Accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur. J. Biochem. 2002; 269: 1996-2002.
67. Cuervo AM. Autophagy and aging: keeping that old broom working. Trends Genet. 2008; 24: 604-612.
68. Rajawat YS, Hilioti Z, Bossis I. Aging: Central role for autophagy and the lysosomal degradative system. Ageing Res. Rev. 2009; 8: 199-213.
69. Salminen A, Kaarniranta K. Regulation of the aging process by autophagy. Trends Mol. Med. 2009; 15: 217-224.
70. Green DR, Galluzzi L, Kroemer G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 2011; 333: 1109-1112.
71. Rubinsztein DC, Marino G, Kroemer G. Autophagy and aging. Cell 2011; 146: 682-695.
72. Rezzani R, Stacchiotti A, Rodella LF. Morphological and biochemical studies on aging and autophagy. Ageing Res. Rev. 2012; 11: 10-31.
73. Toth ML, Sigmond T, Borsos E, Barna J, Erdelyi P, Takacs- Vellai K, Orosz L, Kovacs AL, Csikos G., Sass M, Vellai T. Lonevity pathways converge on autophagy genes to regulate life span in Caenorhabditis elegans. Autophagy 2008; 4: 330-338.
74. Yang L, Li P, Fu S, Calay ES, Hotamisligil GS. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 2010; 11: 467-478.
75. Wu JJ, Quijano C, Chen E, Liu H, Cao L, Fergusson MM, Rovira II, Gutkind S, Daniels MP, Komatsu M, Finkel T. Mitochondrial dysfunction and oxidative stress mediate the physiological impairment induced by the disruption of autophagy. Aging (Albany NY) 2009; 1: 425-437.
76. Cuervo AM, Dice JF. Age-related decline in chaperonemediated autophagy. J. Biol. Chem. 2000; 275: 31505-31513.
77. Zhang C, Cuervo AM. Restoration of chaperone-mediated autophagy in aging liver improves cellular maintenance and hepatic function. Nat. Med. 2008; 14: 959-965.
78. Simonsen A, Cumming RC, Brech A, Isakson P, Schubert DR, Finley KD. Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila. Autophagy 2008; 4: 176-184.
79. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter CS, Pahor M, Javors MA, Fernandez E, Miller RA. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009; 460: 392-395.
80. Madeo F, Tavernarakis N, Kroemer G. Can autophagy promote longevity? Nat. Cell Biol. 2010; 9: 842-846.
81. Bishop NA, Guarente L. Genetic links between diet and lifespan: shared mechanisms from yeast to humans. Nat. Rev. Genet. 2007; 8: 835-844.
82. Bergamini E, Cavallini G, Donati A, Gori Z. The role of autophagy in aging: its essential part in the anti-aging mechanism of caloric restriction. Ann. N.Y. Acad. Sci. 2007; 1114:69-78.
83. Jia K, Levine B. Autophagy is required for dietary restrictionmediated life span extension in C. elegans. Autophagy 2007; 3: 597-599.
84. Colman TJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM, Allison DB, Cruzen C, Simmons HA, Kemnitz JW, Weindruch R. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009; 325: 201-204.
85. Holloszy JO, Fontana L. Caloric restriction in humans. Exp. Gerontol. 2007; 42: 709-712.
86. Morgan TE, Wong AM, Finch CE. Anti-inflammatory mechanisms of dietary restriction in slowing aging processes. Interdiscip. Top. Gerontol. 2007; 35: 83-97.
87. Page MM, Robb EL, Salway KD, Stuart JA. Mitochondrial redox metabolism: aging, longevity and dietary effects. Mech. Ageing Dev. 2010; 131: 242-252.
88. Hagopian K, Chen Y, Simmons Domer K, Soo Hoo R, Bentley T, McDonald RB, Ramsey JJ. Caloric restriction influences hydrogen peroxide generation in mitochondrial sub-populations from mouse liver. J. Bioenerg. Biomembr. 2011; 43: 227-236.
89. Seo AY, Joseph AM, Dutta D, Hwang JC, Aris JP, Leeuwenburgh C. New insights into the role of mitochondria in aging: mitochondrial dynamics and more. J. Cell Sci. 2010; 123: 2533-2542.
90. Weber TA, Reichert AS. Impaired quality control of mitochondria: aging from a new perspective. Exp. Gerontol. 2010; 45: 503-511.
91. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, Bohlooly YM, Gidlof S, Oldfors A, Wibom R, Tornell J, Jacobs HT, Larsson NG. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 2004; 429: 417-423.
92. Gloire G, Legrand-Poels S, Piette J. NF-κB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 2006; 72: 1493-1505.
93. Pantano C, Reynaert NL, Van der Vliet A, Janssen-Heininger YMW. Redox-sensitive kinases of the nuclear factor-κB signaling pathway. Antioxid. Redox Signal. 2006; 8: 1791-1806.
94. Morgan MJ, Liu Z. Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res. 2011; 21: 103-115.
95. Qing G, Yan P, Xiao G. Hsp90 inhibition results in autophagymediated proteasomes-independent degradation of IκB kinase (IKK). Cell Res. 2006; 16: 895-901.
96. Qing G. Yan P, Qu Z, Liu H, Xiao G. Hsp90 regulates processing of NF-κB2 p100 involving protection of NF-κBinducing kinase (NIK) from autophagy-mediated degradation. Cell Res. 2007; 17:520-530.
97. Niida M, Tanaka M, Kamitani. Downregulation of active IKKβ by Ro52-mediated autophagy. Mol. Immunol. 2010; 47: 2378-2387.
98. Johansen T, Lamark T. Selective autophagy mediated by autophagic adapter proteins. Autophagy 2011; 7: 279-296.
99. Bjorkoy G, Lamark T, Johansen T. p62/SQSTM1: a missing link between protein aggregates and the autophagy machinery. Autophagy 2006; 2: 138-139.
100. Moscat J, Diaz-Meco MT, Wooten MW. Signal integration and diversification through the p62 scaffold protein. Trends Biochem. Sci. 2007; 32: 95-100.
101. Djavaheri-Mergny M, Amelotti M, Mathieu J, Besancon F, Bauvy C, Souquere S, Pierron G, Codogno P. NF-κB activation represses tumor necrosis factor-α-induced autophagy. J. Biol. Chem. 2006; 281: 30373-30382.
102. Busillo JM, Azzam KM, Cidlowski JA. Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome. J. Biol. Chem. 2011; 286: 38703-38713.
103. Tsang CK, Qi H, Liu LF, Zheng XFS. Targeting mammalian target of rapamycin (mTOR) for health and diseases. Drug Discov. Today 2007; 12: 112-124.
104. Benjamin D, Colombi M, Moroni C, Hall MN. Rapamycin passes the torch: a new generation of mTOR inhibitors. Nat. Rev. Drug Discov. 2011; 10: 868-880.
105. Fogarty S, Hardie DG. Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim. Biophys. Acta 2010; 1804: 581-591.
106. Vingtdeux V, Chandakkar P, Zhao H, d'Abramo C, Davis P, Marambaud P. Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-β peptide degradation. FASEB J. 2011; 25: 219-231.
107. Blagosklonny MV. Aging. ROS or TOR. Cell Cycle 2008; 7: 3344-3354.
108. Kapahi P, Chen D, Rogers AN, Katewa SD, Li PW, Thomas EL. With TOR, Less is more: a key role for the conserved nutrientsensing TOR pathway in Aging. Cell Metab. 2010; 11: 453-465.
109. Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 2011; 12: 21-35.
110. Blagosklonny MV. Rapamycin and quasi-programmed aging. Four years later. Cell Cycle 9; 10: 1859-1862.
111. Blagosklonny MV. Calorie restriction. Decelerating mTORdriven aging from cells to organisms (including humans). Cell Cycle 2010; 9: 683-688.
112. Anisimov VN, Zabezhinski MA, Popovich IG, Piskunova TS, Semenchenko AV, Tyndyk ML, Yurova MN, Rosenfeld SV, Blagosklonny MV. Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle 2011; 10: 4230-4236.
113. Anisimov VN, Zabezhinski MA, Popovich IG, Piskunova TS, Semenchenko AV, Tyndyk ML, Yurova MN, Antoch MP, Blagosklonny MV. Rapamycin extends maximal lifespan in cancer-prone mice. Am. J. Pathol. 2010; 176: 2092-2097.
114. Cao K, Graziotto JJ, Blair CD, Mazzulli JR, Erdos MR, Krainc D, Collins FS. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells. Sci. Transl. Med. 2011; 3: 89ra58.
115. Majumder S, Caccamo A, Medina DX, Benavides AD, Javors MA, Kraig E, Strong R, Richardson A, Oddo S. Life-long rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and NMDA signaling. Aging Cell 2012; doi: 101111/j.1474-9726.2011.00791.x.
116. Mawhinney LJ, de Vaccari Rivero JP, Dale GA, Keane RW, Bramlett HM. Heightened inflammasome activation is linked to age-related cognitive impairment in Fischer 344 rats. BMC Neurosci. 2011; 12: 123.
117. Steinberg GR, Kemp BE. AMPK in health and disease. Physiol. Rev. 2009; 89: 1025-1078.
118. Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat. Cell Biol. 2011; 13: 1016-1023.
119. Salminen A, Kaarniranta K. AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network. Ageing Res. Rev. 2012; 11: 230-241.
120. Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, Vasquez DS, Joshi A, Gwinn DM, Taylor R, Asara JM, Fitzpatrick J, Dillin A, Viollet B, Kundu M, Hansen M, Shaw RJ. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 2011; 331: 456-461.
121. Reznick RM, Zong H, Li J, Morino K, Moore IK, Yu HJ, Liu ZX, Dong J, Mustard KJ, Hawley SA, Befroy D, Pypaert M, Hardie DG, Young LH, Shulman GI. Aging-associated reductions in AMPKactivated protein kinase activity and mitochondrial biogenesis. Cell. Metab. 2007; 5: 151-156.
122. Liu F, Benashski SE, Persky R, Xu Y, Li J, McCullough LD. Agerelated changes in AMP-activated protein kinase after stroke, Age (Dordr) 2012; 34: 157-168.
123. Salminen A, Hyttinen JM, Kaarniranta K. AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan. J. Mol. Med. (Berl.) 2011; 89: 667-676.
124. Lee JW, Park S, Takahashi Y, Wang HG. The association of AMPK with ULK1 regulates autophagy. PLoS One 2010; 5: e15394.
125. Sanchez AM, Csibi A, Raibon A, Cornille K, Gay S, Bernardi H, Candau R. AMPK promotes skeletal muscle autophagy through activation of forkhead FoxO3a and interaction with Ulk1. J. Cell. Biochem. 2012; 113: 695-710.
126. Kroemer G, Levine B. Autophagic cell death: the story of a misnomer. Nat. Rev. Mol. Cell Biol. 2008; 9: 1004-1010.
127. Shimizu S, Konishi A, Nishida Y, Mizuta T, Nishina H, Yamamoto A, Tsujimoto Y. Involvement of JNK in the regulation of autophagic cell death. Oncogene 2010; 29: 2070-2082.
128. Notte A, Leclere L, Michiels C. Autophagy as a mediator of chemotherapy-induced cell death in cancer. Biochem. Pharmacol. 2011; 82; 427-434.